BioProject

We present the high quality draft assembly of a sample of N.lactamica Y92-1009 (accession number) cell bank purified stock used to artificially induce nasopharyngeal carriage in humans. More...

We present the high quality draft assembly of a sample of N.lactamica Y92-1009 (accession number) cell bank purified stock used to artificially induce nasopharyngeal carriage in humans. This gram negative, dipplococcoid bacterium is an organism of worldwide clinical interest due to its observed inverse carriage relationship with the meningococcus, principle agent of bacterial meningitis, in young children. The organism was originally isolated during the course of a carriage study from the nasopharynx of a young child in Ireland in 1992. This SMRT cell sequenced draft assembly consists of a single contig corrected using reads sequenced on Illumina Miseq 2000 of the same isolate. Less...